secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2024-11-26T23:59:59+00:00
Accession:  0001213900-24-102903
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea enters $2.08M ATM equity facility with H.C. Wainwright
---------------------------------------------------------------

- ATM agreement with H.C. Wainwright for up to $2,076,000 in common stock sales.
- Sales agent commission: 3% of gross proceeds; company reimburses up to $100k in legal fees.
- No minimum obligation; company may suspend or terminate the offering at any time.
- Sales will be made on Nasdaq as 'at the market' offerings per Rule 415.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390024102903/0001213900-24-102903-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390024102903/ea0222547-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-102903

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer